These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Persistency of low levels of anticardiolipin and anti-beta2 glycoprotein1 in thrombosis. Amaral M; Favas C; Delgado Alves J Eur J Intern Med; 2010 Apr; 21(2):101-3. PubMed ID: 20206880 [TBL] [Abstract][Full Text] [Related]
24. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633 [TBL] [Abstract][Full Text] [Related]
25. Height associated with different clinical expressions in primary antiphospholipid syndrome female patients. Freire Carvalho J; Pereira Torales MB; Figueiredo Sousa MI; Larocca Skare T Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):585-590. PubMed ID: 35113434 [TBL] [Abstract][Full Text] [Related]
27. [Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases]. Alcaraz I; Lefevre I; Wiart T; Lafon C; Forzy G; Modiano P Ann Dermatol Venereol; 1999 Apr; 126(4):313-6. PubMed ID: 10421932 [TBL] [Abstract][Full Text] [Related]
28. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome. Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729 [TBL] [Abstract][Full Text] [Related]
29. ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis? Nascimento NM; Bydlowski SP; Soares RP; de Andrade DC; Bonfá E; Seguro LP; Borba EF J Thromb Thrombolysis; 2015 Oct; 40(3):374-8. PubMed ID: 25638331 [TBL] [Abstract][Full Text] [Related]
30. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity]. Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587 [TBL] [Abstract][Full Text] [Related]
31. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome. Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877 [TBL] [Abstract][Full Text] [Related]
32. Thrombotic microangiopathy in patients with phosphatidylserine dependent antiprothrombin antibodies and antiphospholipid syndrome. Kon Y; Atsumi T; Hagiwara H; Furusaki A; Kataoka H; Horita T; Yasuda S; Amengual O; Takao K Clin Exp Rheumatol; 2008; 26(1):129-32. PubMed ID: 18328160 [TBL] [Abstract][Full Text] [Related]
33. Low prevalence of antiannexin A5 antibodies in unprovoked venous thrombosis. Ho WK; Rigano J Int J Lab Hematol; 2021 Oct; 43(5):1225-1228. PubMed ID: 33586909 [TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke? Camargo EW; Freire PV; Silva CA; dos Santos NR; da Mota LM; Pereira RM; de Carvalho JF Rheumatol Int; 2012 Jun; 32(6):1721-5. PubMed ID: 21437687 [TBL] [Abstract][Full Text] [Related]
35. Thrombotic microangiopathy associated with anticardiolipin antibody in a kidney transplant recipient with polycythemia. Tsuchimoto A; Matsukuma Y; Ueki K; Nishiki T; Doi A; Okabe Y; Nakamura M; Tsuruya K; Nakano T; Kitazono T; Masutani K CEN Case Rep; 2019 Feb; 8(1):1-7. PubMed ID: 30073489 [TBL] [Abstract][Full Text] [Related]
37. Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis. Shinzato MM; Bueno C; Trindade Viana VS; Borba EF; Gonçalves CR; Bonfá E Lupus; 2005; 14(12):953-8. PubMed ID: 16425575 [TBL] [Abstract][Full Text] [Related]
38. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E Lupus; 2007; 16(1):39-45. PubMed ID: 17283584 [TBL] [Abstract][Full Text] [Related]
39. Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process? Rollino C; Mazzucco G; Boero R; Beltrame G; Quattrocchio G; Ferro M; Milan M; Berruti S; Quarello F Ren Fail; 2003 Nov; 25(6):1043-9. PubMed ID: 14669864 [TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome. Rodríguez-Sanz A; Martínez-Sánchez P; Prefasi D; Fuentes B; Pascual-Salcedo D; Blanco-Bañares MJ; Díez-Tejedor E Autoimmunity; 2015; 48(5):275-81. PubMed ID: 25434364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]